Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 44Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Myelodysplastic Syndromes 26Hematologic Neoplasms 20Lymphoma, Non-Hodgkin 19Multiple Myeloma 18Lymphoma 18Recurrence 15Lymphoma, B-Cell 14Lymphoma, Large B-Cell, Diffuse 13Leukemia, Lymphocytic, Chronic, B-Cell 12Burkitt Lymphoma 12Breast Neoplasms 11Pancreatic Neoplasms 10Ovarian Neoplasms 10Lymphoma, Follicular 10Neoplasm Metastasis 9Melanoma 9Leukemia, Myelomonocytic, Chronic 9Myeloproliferative Disorders 8Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Biphenotypic, Acute 7Leukemia 7Hodgkin Disease 7Glioblastoma 7Carcinoma, Non-Small-Cell Lung 7Triple Negative Breast Neoplasms 6Stomach Neoplasms 6Osteosarcoma 6

Interventions

Cytarabine 7Cyclophosphamide 7Dexamethasone 6venetoclax 4blinatumomab 4Methotrexate 4Inotuzumab Ozogamicin 4pegaspargase 3merphos 3Vincristine 3Specimen Handling 3prednylidene 2dexamethasone acetate 2dexamethasone 21-phosphate 2deltacortene 2calaspargase pegol 2azathiopurine 2auricularum 2Prednisone 2N,N-dicyclohexyl-isoborneol-10-sulfonamide 2Mercaptopurine 2Leucovorin 2Doxorubicin 2Calcium Dobesilate 2Biopsy 2Asparaginase 2trametinib 1ruxolitinib 1olverembatinib 1ofatumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × fludarabine × Clear all
NCT03937544 2025-05-29

Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL

National University of Malaysia

Phase 2/3 Recruiting
10 enrolled
LymphoidOther hematologic neoplasm

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡